News from mylan n.v. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 06, 2020, 06:59 ET Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three and nine months ended September 30, 2020. Third Quarter 2020 Financial...

Nov 02, 2020, 07:30 ET Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris

Mylan N.V. (NASDAQ: MYL) today announced that Bill Szablewski, CFA, has joined the company as Head of Capital Markets, in a new leadership role...

Oct 30, 2020, 13:39 ET Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the "FTC") accepted a proposed consent...

Sep 15, 2020, 07:15 ET Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL

Mylan N.V. (NASDAQ: MYL) today announced that the Technical Board of Appeal of the European Patent Office (EPO) has held that Yeda Research and...

Sep 09, 2020, 13:07 ET Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury, together with President Rajiv Malik...

Sep 09, 2020, 13:05 ET Mylan to Present at the BofA Securities Virtual Global Healthcare Conference

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury, together with President Rajiv Malik...

Sep 08, 2020, 02:00 ET Mylan to Acquire Aspen's Thrombosis Business in Europe

Mylan N.V. (NASDAQ: MYL) today announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare...

Aug 31, 2020, 06:00 ET Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes

Mylan N.V. (NASDAQ: MYL) and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced the U.S....

Aug 28, 2020, 18:30 ET Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up

Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the...

Aug 19, 2020, 07:00 ET Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera®

Mylan N.V. (NASDAQ: MYL) today announced the launch of the first FDA-approved therapeutically equivalent, substitutable generic of Biogen's...

Aug 12, 2020, 09:00 ET Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19

Mylan N.V. (NASDAQ: MYL) and Sesame Workshop, the non-profit educational organization behind Sesame Street, today announced a new effort to help...

Aug 06, 2020, 06:30 ET Mylan Reports Strong Second Quarter and First Half 2020 Results and Updates 2020 Guidance

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three and six months ended June 30, 2020. Second Quarter 2020 Financial...

Jul 22, 2020, 07:30 ET Mylan to Release Second Quarter 2020 Financial Results on Aug. 6, 2020

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its second quarter 2020 financial results on Thurs., Aug. ...
Viatris Reveals Branding to Reflect New Company's Transformative Strategy

Jul 09, 2020, 08:31 ET Viatris Reveals Branding to Reflect New Company's Transformative Strategy

Mylan N.V. (NASDAQ: MYL) and Upjohn, a division of Pfizer, today unveiled the logo and branding for VIATRIS™, the new company that will be formed by...

Jul 09, 2020, 06:30 ET Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp)

Mylan N.V. (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved...

Jul 07, 2020, 11:35 ET Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to the Presence of Particulate

Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the...

Jul 06, 2020, 06:00 ET Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients

Mylan N.V. (NASDAQ: MYL) today announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted...

Jun 30, 2020, 11:33 ET Mylan Shareholders Overwhelmingly Approve Proposed Combination with Upjohn

Mylan N.V. (Nasdaq: MYL) today announced that its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan and Upjohn, a ...

Jun 18, 2020, 16:04 ET Mylan Wins District Court Decision Against Biogen's Tecfidera® Patent

Mylan N.V. (NASDAQ: MYL) today announced that the U.S. District Court for the Northern District of West Virginia invalidated Biogen's Tecfidera®...

Jun 18, 2020, 06:59 ET Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn

Upjohn Inc. ("Newco"), a wholly-owned subsidiary of Pfizer Inc. ("Pfizer") (NYSE: PFE), Upjohn Finance B.V. ("Finco"), a wholly-owned subsidiary of...

Jun 11, 2020, 18:35 ET Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)

Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food and Drug Administration (FDA) has...

Jun 04, 2020, 08:00 ET Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mylan N.V. (NASDAQ: MYL) and Lupin Limited (Lupin) today announced that the European Commission (EC) has granted marketing authorization for...

May 29, 2020, 15:24 ET Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings

Mylan N.V. (NASDAQ: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review...

May 13, 2020, 12:23 ET Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury and President Rajiv Malik will present ...

May 12, 2020, 16:16 ET Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19

Mylan N.V. (NASDAQ: MYL) today announced, as part of its ongoing efforts to support patients and public health needs during the COVID-19 pandemic, a...